Unwanted effects of morphine-6-glucuronide and morphine

Anaesthesia

Volumn 57, Issue 12, 2002, Pages 1200-1203

  Cann, C ^a,b   Curran, J ^a   Milner, T ^a,c   Ho, B ^a,d  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c NORTH TYNESIDE GENERAL HOSPITAL   (United Kingdom)

^d DERBY CITY GENERAL HOSPITAL   (United Kingdom)

Author keywords

Analgesics: morphine morphine 6 glucuronide; Vomiting: incidence, nausea

Indexed keywords

ANALGESIC AGENT; ANTIEMETIC AGENT; DICLOFENAC; KETOROLAC; MORPHINE 6 GLUCURONIDE; MORPHINE SULFATE; NARCOTIC ANALGESIC AGENT; PARACETAMOL; PROCHLORPERAZINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG ERUPTION; DRUG POTENCY; FEMALE; GENERAL ANESTHESIA; HUMAN; INCIDENCE; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; POSTOPERATIVE NAUSEA; POSTOPERATIVE NAUSEA AND VOMITING; POSTOPERATIVE PAIN; POSTOPERATIVE VOMITING; PRURITUS; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SEDATION; SOMNOLENCE; TOXICITY;

ADOLESCENT; ADULT; AGED; AMBULATORY SURGICAL PROCEDURES; ANALGESICS, OPIOID; ANESTHESIA, GENERAL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LAPAROSCOPY; MIDDLE AGED; MORPHINE; MORPHINE DERIVATIVES; ODDS RATIO; PAIN, POSTOPERATIVE; POSTOPERATIVE NAUSEA AND VOMITING;

EID: 0036897440     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2044.2002.02624_2.x     Document Type: Article

References (29)

1. Christup LL. Morphine metabolites. Acta Anaesthesiologica Scandinavica 1997; 41: 116-22.
2. Pasternak GW, Bodnar RJ, Clark JA, Inturrisi CE. Morphine-6-glucuronide, a potent mu agonist. Life Sciences 1987; 41: 2845-9.
3. Francés B, Gout R, Campistron G, Panconi E, Cros J. Morphine-6-glucuronide is more mu selective and potent in analgesic tests than morphine. Progress in Clinical and Biological Research 1990; 39: 477-80.
4. Christensen CB, Reiff L. Morphine-6-glucuronide receptor binding profile in bovine caudate nucleus. Pharmacology and Toxicology 1991; 68: 151-3.
5. Francés B, Gout R, Monsarrat B, Cros J, Zajac J-M. Further evidence that morphine-6α-glucuronide is a more potent opioid agonist than morphine. Journal of Pharmacology and Experimental Therapeutics 1992; 262: 25-31.
6. Hanna MH, Peat SJ, Woodham M, Knibb A, Fung C. Analgesic efficacy and CSF pharmacokinetics of intrathecal morphine-6-glucuronide: Comparison with morphine. British Journal of Anaesthesia 1990; 64: 547-550.
7. Grace D, Fee JPH. A comparison of intrathecal morphine-6-glucuronide and intrathecal morphine sulfate as analgesics for total hip replacement. Anesthesia and Analgesia 1996; 83: 1055-9.
8. Paul D, Kelly MS, Inturrisi CE, Pasternack GW. Pharmacological characterisation of morphine-6β glucuronide, a very potent morphine metabolite. Journal of Pharmacology and Experimental Therapeutics 1989; 251: 477-83.
9. Gong Q-L, Hedner T, Bjorkman R, Nordberg G. Antinoceptive and ventilatory effects of the mophine metabolites morphine-6-glucuronide and morphine-3-glucuronide. European Journal of Pharmacology 1991; 193: 47-56.
10. Osborne R, Joel S, Trew D, Slevin M. Analgesic activity of morphine-6-glucuronide. Lancet 1988; i: 828.
11. Osborne R, Thompson P, Joel S, Trew D, Patel N, Slevin M. Analgesic activity of morphine-6-glucuronide. British Journal of Clinical Pharmacology 1992; 34: 130-8.
12. Thompson PI, Joel SP, John L, Wedzicha JA, Maclean M, Slevin M. Respiratory depression following morphine and morphine-6-glucuronide in normal subjects. British Journal of Clinical Pharmacology 1995; 40: 145-52.
13. Durcan T, Jones N, Timberlake C, et al. The respiratory and analgesic response to morphine-6-glucuronide in the clinical setting in man. Abstracts, 8th World Congress on Pain. Vancouver: IASP Press, 1996: 396.
14. Geisslinger G, Brune K, Kobal G, Lötsch J. Intravenous morphine-6-glucuronide is devoid of analgesic activity in man. Pain 1996; 64: 289-90.
15. Lötsch J, Kobal G, Stockmann A, Brune K, Geisslinger G. Lack of analgesic activity of morphine-6-glucuronide after short-term intravenous administration in healthy volunteers. Anesthesiology 1997; 87: 1348-58.
16. Motamed C, Mazoit X, Ghanouchi K, et al. Pre-emptive intravenous morphine-6-glucuronide is ineffective for post-operative pain relief. Anesthesiology 2000; 92: 355-60.
17. Buetler TM, Wilder-Smith OHG, Wilder-Smith CH, Aebi S, Cerny T, Brenneisen R. Analgesic potency of i.v. morphine in healthy volunteers. British Journal of Anaesthesia 2000; 84: 97-9.
18. Penson RT, Joel S, Bakhshi K, Clark SJ, Langford R, Slevin M. Randomised placebo-controlled trial of the morphine glucuronides. Clinical Pharmacology and Therapeutics 2000; 68: 667-76.
19. Hanna MH, Peat SJ, Knibb AA, Fung C. Disposition of morphine-6-glucuronide and morphine in healthy volunteers. British Journal of Anaesthesia 1991; 66: 103-7.
20. Peat SJ, Hanna MH, Woodham M, Knibb AA, Ponte J. Morphine-6-glucuronide: Effects on ventilation in normal volunteers. Pain 1991; 45: 101-4.
21. Pellegron DA, Riegler FX, Albrecht RF. Ventilatory effect of fourth cerebro-ventricular infusions of morphine-6- or morphine-3 glucuronide in the awake dog. Anesthesiology 1989; 71: 936-44.
22. Thompson PI, Bingham S, Andrews PLR, Patel N, Joel SP, Slevin ML. Morphine-6-glucuronide: A metabolite of morphine with greater emetic potency than morphine in the ferret. British Journal of Pharmacology 1992; 106: 3-8.
23. Kamath B, Curran J, Hawkey C, Beattie A, Gorbutt N, Guiblin H. Anaesthesia, movement and emesis. British Journal of Anaesthesia 1990; 64: 728-30.
24. Palazzo M, Evans R. Logistic regression analysis of fixed patient factors for post-operative sickness: A model for risk assessment. British Journal of Anaesthesia 1993; 70: 135-40.
25. Cholwill JM, Wright W, Hobbs GJ, Curran J. Comparison of ondansetron and cyclizine for prevention of nausea and vomiting after day-case gynaecological laparoscopy. British Journal of Anaesthesia 1999; 83: 611-14.
26. Ahmed AB, Hobbs GJ, Curran J. Combination antiemetics and day-case gynaecological laparoscopic surgery: A randomised double-blind controlled trial. British Journal of Anaesthesia 2000; 85: 678-82.
27. Mallins AF, Field JM, Nestling PM, Cooper GM. Nausea and vomiting after gynaecological laparoscopy, comparison of premedication with oral ondansetron, metoclopramide and placebo. British Journal of Anaesthesia 1994; 72: 231-3.
28. Simpson RB, Russell D. Anaesthesia for daycase gynaecological laparoscopy: A survey of clinical practice in the United Kingdom. Anaesthesia 1999; 54: 72-6.
29. Bickel U, Schumacher OP, Kang YS, Voigt K. Poor permeability of morphine-3-glucuronide through the blood-brain barrier in the rat. Journal of Pharmacology and Experimental Therapeutics 1996; 278: 107-13.